Development and validation of a combined radiomic and clinical model based on contrast-enhanced ultrasound for preoperative prediction of CK19-positive hepatocellular carcinoma.

Purpose: We aimed to develop and validate a combined model integrating radiomic features derived from Contrast-Enhanced Ultrasound (CEUS) images and clinical parameters for preoperative prediction of CK19-positive status in hepatocellular carcinoma (HCC). Methods: A total of 434 patients who underwe...

Descripción completa

Detalles Bibliográficos
Publicado en:Abdominal Radiology Vol. 50; no. 8; pp. 3516 - 3530
Autores principales: Liang, Li, Pang, Jin-shu, Gao, Rui-zhi, Que, Qiao, Wu, Yu-quan, Peng, Jin-bo, Bai, Xiu-mei, Qin, Qiong, Tang, Quan-quan, Li, Li-peng, He, Yun, Yang, Hong
Formato: Journal Article
Publicado: Springer Nature Aug2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186678331&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 186678331
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        2366004X
        JT14
      jtl: Abdominal Radiology
      issn: 2366004X
      maglogo: N
    pubinfo:
      dt: Aug2025
      vid: 50
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        186678331
        182790536
        10.1007/s00261-025-04799-x
        186678331
      ppf: 3516
      ppct: 14
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Development and validation of a combined radiomic and clinical model based on contrast-enhanced ultrasound for preoperative prediction of CK19-positive hepatocellular carcinoma.
      aug:
        au:
          Liang, Li
          Pang, Jin-shu
          Gao, Rui-zhi
          Que, Qiao
          Wu, Yu-quan
          Peng, Jin-bo
          Bai, Xiu-mei
          Qin, Qiong
          Tang, Quan-quan
          Li, Li-peng
          He, Yun
          Yang, Hong
        affil: https://ror.org/030sc3x20 Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region, China
      sug:
      ab: Purpose: We aimed to develop and validate a combined model integrating radiomic features derived from Contrast-Enhanced Ultrasound (CEUS) images and clinical parameters for preoperative prediction of CK19-positive status in hepatocellular carcinoma (HCC). Methods: A total of 434 patients who underwent CEUS and surgical resection from January 2020 to December 2023 were included. Patients were randomly divided into a training cohort (n = 304) and a validation cohort (n = 130). Radiomic features were extracted from multiphase CEUS images, including two-dimensional ultrasound (US), arterial, portal venous, and delayed phases, and combined to derive a Radscore model. Subsequently, a Combined Model was constructed using the Radscore and clinical parameters. Model performance was assessed using calibration, discrimination, and clinical utility. Results: Multivariate logistic regression analysis identified Radscore (OR = 10.054, 95% CI: 5.931–19.120, p < 0.001) and AFP levels > 200 ng/mL (OR = 5.027, 95% CI: 2.089–12.784, p < 0.001) as significant predictors in the combined model. The AUC (Area Under the Curve) for the Combined Model was 0.954 in the training cohort and 0.927 in the validation cohort, compared to 0.939 and 0.917 for the Radscore Model alone. Calibration curves demonstrated strong concordance between predicted and actual outcomes. Decision curve analysis (DCA) showed that both the Radscore Model and the Combined Model exhibited good net benefits across a wide range of threshold values in both the training and validation cohorts. Conclusion: The Radscore based on CEUS, combined with the serum markers AFP > 200 ng/L to construct a Combined Model, shows good predictive performance for CK19 + hepatocellular carcinoma (HCC).
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N